{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:41:10Z","timestamp":1768693270726,"version":"3.49.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cystic fibrosis related diabetes (CFRD) is a comorbidity of cystic fibrosis (CF) that negatively impacts on its clinical course. Prediabetes is an important predictor of either CFRD development and unfavorable prognosis of CF in both pediatric and adult patients. International guidelines recommend insulin only in case of CFRD diagnosis. Whether early detection and treatment of prediabetes may contribute to improve the clinical course of CF is still debated. A subgroup of pediatric diabetologists of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED) performed a systematic review of the literature based on predefined outcomes: impact of pre-diabetes on clinical outcomes and on the risk of developing CFRD; diagnosis of diabetes and pre-diabetes under 10 years of age; effectiveness of therapy on glycemic control, impact of therapy on pulmonary function and nutritional status. Thirty-one papers were selected for the analysis data presented in these papers were reported in tables sorted by outcomes, including comprehensive evidence grading according to the GRADE approach. Following the grading of the quality of the evidence, the entire ISPED diabetes study group achieved consensus for the Italian recommendations based on both evidence and clinical experience. We concluded that in patients with CF, prediabetes should be carefully considered as it can evolve into CFRD. In patients with CF and prediabetic conditions, after complete evaluation of the OGTT trend, glucometrics, glycemic values measured during pulmonary exacerbations and\/or steroid therapy, early initiation of insulin therapy could have beneficial effects on clinical outcomes of patients with CF and prediabetes.<\/jats:p>","DOI":"10.3389\/fendo.2021.673539","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:37:25Z","timestamp":1619674645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)"],"prefix":"10.3389","volume":"12","author":[{"given":"Enza","family":"Mozzillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Piona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Passanisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Casertano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina","family":"Pjetraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Maltoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Cauvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Paola","family":"Frongia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Lo Presti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Matteoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Piccinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Predieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Enzo","family":"Scaramuzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Toni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Maffeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Schiaffini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0586","article-title":"Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1215","article-title":"Diabetes as a Determinant of Mortality in Cystic Fibrosis","volume":"33","author":"Chamnan","year":"2010","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00632.x","article-title":"Oral glucose tolerance testing in children with cystic fibrosis","volume":"11","author":"Ode","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa932","article-title":"Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function","author":"Piona","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD004730.pub5","article-title":"Drug treatments for managing cystic fibrosis-related diabetes. Cochrane Cystic Fibrosis and Genetic Disorders Group, ed","author":"Onady","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.07.044","article-title":"Abnormal glucose tolerance in a pediatric cystic fibrosis cohort: Trends in clinical outcomes and associated factors in the preceding years","volume":"31","author":"Nguyen","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B8","unstructured":""},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2018-0222","article-title":"Glucose intolerance in children with cystic fibrosis: a developing country\u2019s perspective","volume":"31","author":"Banavath","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.10.007","article-title":"Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status","volume":"110","author":"Lavie","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.03.001","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","volume":"15","author":"Coriati","year":"2016","journal-title":"J Cyst Fibros"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0005","article-title":"Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function","volume":"30","author":"Terliesner","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.08.020","article-title":"Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index","volume":"2111","author":"Tommerdahl","year":"2020","journal-title":"J Cyst Fibros"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.59268","article-title":"Predictors of deterioration of lung function in Polish children with cystic fibrosis","volume":"2","author":"Olszowiec-Chlebna","year":"2016","journal-title":"aoms"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23042","article-title":"Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis: Cystic Fibrosis-Related Diabetes and Pubertal Growth","volume":"50","author":"Bizzarri","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119938","article-title":"Sputum Glucose and Glycemic Control in Cystic Fibrosis-Related Diabetes: A Cross-Sectional Study","volume":"10","author":"Van Sambeek","year":"2015","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2621-0","article-title":"Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes","volume":"35","author":"Limoli","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12890-017-0416-4","article-title":"Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis","volume":"17","author":"Reece","year":"2017","journal-title":"BMC Pulm Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2888","article-title":"Incidence and Risk Factors for Multiple Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis","volume":"132","author":"Merlo","year":"2007","journal-title":"Chest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"J Cyst Fibros"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23237","article-title":"Elevation of one hour plasma glucose during oral glucose tolerance testing: 1-Hour Plasma Glucose and Cystic Fibrosis","volume":"50","author":"Sheikh","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1020","article-title":"Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system","volume":"162","author":"Schiaffini","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201512-2518OC","article-title":"Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis","volume":"194","author":"Yi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-017-0289-9","article-title":"Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life","volume":"8","author":"Fattorusso","year":"2017","journal-title":"Diabetes Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.03.010","article-title":"Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis","volume":"18","author":"Prentice","year":"2019","journal-title":"J Cyst Fibros"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.05.005","article-title":"Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.02.009","article-title":"Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0459","article-title":"Glucose Derangements in Very Young Children With Cystic Fibrosis and Pancreatic Insufficiency","volume":"35","author":"Mozzillo","year":"2012","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2001.tb02446.x","article-title":"Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy","volume":"90","author":"Rolon","year":"2001","journal-title":"Acta Paediatr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2011.050","article-title":"Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study","volume":"24","author":"Kolou\u0161kov\u00e1","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2007.07.004","article-title":"Glargine versus NPH insulin in cystic fibrosis?A3B2 show [#,32] ?> related diabetes","volume":"7","author":"Grover","year":"2008","journal-title":"J Cyst Fibros"},{"key":"B36","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jcf.2018.05.005","article-title":"Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes","volume":"17","author":"Frost","year":"2018","journal-title":"J Cyst Fibros"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1399-5448.2011.00810.x","article-title":"Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial","volume":"13","author":"Minicucci","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0585","article-title":"Insulin Therapy to Improve BMI in Cystic Fibrosis-Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes","volume":"8","author":"Hardin","year":"2009","journal-title":"J Cyst Fibros"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa167","article-title":"Semaglutide in Cystic Fibrosis-Related Diabetes","volume":"105","author":"Gnanapragasam","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13912","article-title":"Association between HbA 1c and the development of cystic fibrosis-related diabetes","volume":"36","author":"Choudhury","year":"2019","journal-title":"Diabetes Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00068104","article-title":"New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis","volume":"25","author":"Mueller-Brandes","year":"2005","journal-title":"Eur Respir J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"00002","DOI":"10.1016\/j.jcf.2021.01.002","article-title":"Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring","author":"Elidottir","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.673539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T15:08:54Z","timestamp":1620140934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.673539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":47,"alternative-id":["10.3389\/fendo.2021.673539"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.673539","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"article-number":"673539"}}